BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role
Zsuzsa Nagy-Baló1,2, Richárd Kiss3, Judit Demeter4
1Department of Immunology, Eötvös Loránd University, Budapest, Hungary.
Insights
The study reveals that CD11b and CD11c receptors on chronic lymphocytic leukaemia (CLL) B cells promote disease progression by mediating cell adhesion and migration. These findings explain why CD11c presence worsens CLL prognosis.
Area of Science:
- Immunology
- Hematology
- Cell Biology
Background:
- Chronic lymphocytic leukaemia (CLL) is the most prevalent leukaemia in Western countries.
- Previous studies identified CD11b+ or CD11c+ B cells as unfavorable prognostic factors in CLL, but the underlying mechanisms remain unclear.
Purpose of the Study:
- To investigate the role of CD11b and CD11c in the pathogenesis of CLL.
- To analyze the involvement of these receptors in B cell adhesion to fibrinogen and migration towards stromal cell-derived factor-1 (SDF-1).
Main Methods:
- Analysis of CD11b and CD11c expression on CLL B cells.
- Assays to study B cell adhesion to fibrinogen.
- Migration assays using SDF-1 as a chemoattractant.
- Investigation of the CR4 receptor's role in the CD11c+ B cell line BJAB.
Main Results:
- Both complement receptor 3 (CR3, mediated by CD11b) and CR4 (mediated by CD11c) were found to mediate the adhesion of malignant B cells.
- CR4 significantly contributed to the migration of leukemic cells towards SDF-1.
- These receptors are active players in CLL pathogenesis, not just passive markers.
Conclusions:
- CR3 and CR4 play active roles in chronic lymphocytic leukaemia progression.
- The findings elucidate how CD11c expression on leukemic B cells can negatively impact CLL prognosis, particularly concerning migration to the bone marrow for survival.
Abstract:
Chronic lymphocytic leukaemia (CLL) is the most common leukaemia in the western world. In previous studies, various proportion of patients was found to carry CD11b+ or CD11c+ B cells whose presence was an unfavourable prognostic factor. The exact mechanism however, how these receptors contribute to the pathogenesis of CLL has not been revealed so far. Here we analysed the role of CD11b and CD11c on B cells of CLL patients in the adhesion to fibrinogen and in the migration towards stromal cell derived factor-1 (SDF-1) and studied the role of CR4 in the adherence of the CD11c+ B cell line BJAB. We observed that both CR3 and CR4 mediate adhesion of the malignant B cells. Moreover, we found, that CR4 was strongly involved in the migration of the leukemic cells towards the chemoattractant SDF-1. Our data suggest that CR3 and CR4 are not only passive markers on CLL B cells, but they might contribute to the progression of the disease. Since the role of SDF-1 is prominent in the migration of CLL cells into the bone marrow where their survival is supported, our findings help to understand how the presence of CD11c on leukemic B cells can worsen the prognosis of chronic lymphocytic leukaemia.
More Related Videos
10:25Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
Published on: September 20, 2019
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
Related Concept Videos
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Intracellular Signaling Affects Focal Adhesions
Some...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cell Polarization by Rho Proteins
